Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors

This was the stock's second consecutive day of losses.

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...
MyChesCo on MSN

INOVIO Announces Equity Grant Under 2022 Inducement Plan

INOVIO (NASDAQ: INO) announced that it has granted a stock option to a newly hired employee under the company’s 2022 Inducement Plan, as approved by the ...

INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat ...